Dow Down 1.02% Nasdaq Down 1.00%

Vanda Pharmaceuticals, Inc. (VNDA)

-NasdaqGM
10.29 Down 0.09(0.87%) 12:29PM EDT - Nasdaq Real Time Price
Prev Close:10.38
Open:10.42
Bid:10.26 x 100
Ask:10.27 x 200
1y Target Est:27.50
Beta:2.17
Earnings Date:Nov 5 - Nov 10 (Est.)
Day's Range:10.05 - 10.49
52wk Range:5.70 - 19.25
Volume:153,815
Avg Vol (3m):518,239
Market Cap:348.59M
P/E (ttm):N/A
EPS (ttm):-1.83
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
VNDADown 0.87%348.59M
AZNDown 1.04%89.29B
LLYUp 0.48%69.83B
JNJDown 2.14%294.18B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):9.38
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-2.00
Quarterly EPS Est (Sep-14) :-0.39
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):-0.36

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Vanda Pharmaceuticals Inc., a biopharmaceutical company, is engaged in the development and commercialization of pharmaceutical products. Its product portfolio includes HETLIOZ, a product for the treatment of Non-24-Hour Sleep-Wake Disorder; Fanapt... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback